Stanford University School of Medicine researcher Matthew Porteus, MD, PhD, was one of three expert witnesses who spoke at a U.S. Senate committee hearing on …
Author: Christopher Vaughan
Study shows cancer therapy may work in new and unexpected way
The body’s immune cells constantly work to achieve the right balance between being shoot-first, ask-questions-later enforcers that efficiently wipe out all diseased and infected cells …
Cancer uses inflammatory pathways to protect itself
In recent years, scientists in the laboratory of Stanford's Irving Weissman, MD, discovered that cancer cells cover themselves in copies of the CD47 “don’t eat me” …
Resetting leukemia cells
The question sounds more like sociology than biology: What would happen if you could take a cell gone bad -- a cancer cell -- bring …
Could immunotherapy be helpful for cancer in dogs?
Four years ago, Irv Weissman, MD, and his lab at Stanford’s Institute for Stem Cell Biology and Regenerative Medicine published a paper showing that, in …
New Stanford-developed tool allows easier study of blood cancers
In the history of science and medicine, the breakthrough discoveries get a lot of deserved attention, but often overlooked are the invention of the tools …
Near approval: A stem cell gene therapy developed by Stanford researcher
It has been a momentous month for Stanford researcher Maria Grazia Roncarolo, MD. Following decades of research in Roncarolo’s lab and the clinic, pharmaceutical company …
Stanford stem cell experts highlight “inherent flaw” in drug development system
Academic institutions are in a much better position than pharmaceutical companies to make the best decisions about which therapies deserve further development. That was the …
“It’s not just science fiction anymore”: Childx speakers talk stem cell and gene therapy
At the Childx conference last week there was a great deal of optimism that stem cell and genetic therapies are about to have a huge impact …
Researchers celebrate 25th anniversary of major stem cell discovery
A new era of stem cell science began 25 years ago. At that time, Stanford researcher Irving Weissman, MD, and his colleagues announced in Science that …
Ocean organism settles down, digests its proto-brain and loses its individuality
Last week, Science published a research report from Stanford scientists on the discovery of a single gene in a primitive marine organism that determines whether that …
Stanford computer scientist shows stem cell researchers the power of big data
Not long ago, Stanford computer scientist Debashis Sahoo, PhD, told investigators at the Stanford Institute for Stem Cell Biology and Regenerative Medicine that in a …
Blood cancers shown to arise from mutations that accumulate in stem cells
How and why do some cells in our bodies become cancerous? Can any cell become cancerous, or only certain kinds of cells? Those are longstanding questions …
Image of the Week: "Heart cells"
As I reported in this week's issue of Inside Stanford Medicine, Scott Metzler, PhD, is a researcher who not only studies the early development of …
Medicine is about to be “Schumpetered" – and go through its biggest shake-up in history
Digital technologies and social networks will cause medicine's biggest shakeup in history, an expert says.
Digital technologies and social networks will cause medicine's biggest shakeup in history, an expert says.
Cancer stem cell researchers are feeling the need for speed
Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.
Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.